Stakeholder Insights into Czech Performance-Based Managed Entry Agreements: Potential for Transformative Change in Pharmaceutical Access?

Stakeholder Insights into Czech Performance-Based Managed Entry Agreements: Potential for Transformative Change in Pharmaceutical Access?

Managed Entry Agreements (MEAs) play a pivotal role in addressing the challenges arising from escalating prices of innovative medical technologies, especially in areas like oncology, immunology, and rare diseases. Among MEAs, Performance-Based MEAs (PB MEAs) and Outcome-Based MEAs (OB MEAs) stand ou...

Full description

Bibliographic Details
Main Authors: Petra Hospodková, Pavel Karásek, Aleš Tichopád
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Healthcare
Subjects:
performance-based managed entry agreements
stakeholder analysis
qualitative research
innovative medical technology
pharmaceutical industry
risk-sharing
Online Access:https://www.mdpi.com/2227-9032/12/1/119

Internet

https://www.mdpi.com/2227-9032/12/1/119

Similar Items